header logo image header logo text
Downloads Login
Research
General Information
ZIRC
ZFIN ID: ZDB-PUB-140317-30
Overexpression of endothelin 1 triggers hepatocarcinogenesis in zebrafish and promotes cell proliferation and migration through the AKT pathway
Lu, J.W., Liao, C.Y., Yang, W.Y., Lin, Y.M., Jin, S.L., Wang, H.D., and Yuh, C.H.
Date: 2014
Source: PLoS One 9(1): e85318 (Journal)
Registered Authors: Yang, Wan-Yu, Yuh, Chiou-Hwa (Cathy)
Keywords: none
MeSH Terms:
  • Animals
  • Carcinoma, Hepatocellular/etiology
  • Carcinoma, Hepatocellular/genetics*
  • Carcinoma, Hepatocellular/metabolism
  • Carcinoma, Hepatocellular/pathology
  • Cell Cycle
  • Cell Movement
  • Cell Proliferation
  • Endothelin-1/antagonists & inhibitors
  • Endothelin-1/genetics*
  • Endothelin-1/metabolism
  • Fatty Liver/complications
  • Fatty Liver/genetics
  • Fatty Liver/metabolism
  • Fatty Liver/pathology
  • Gene Expression
  • HEK293 Cells
  • Humans
  • Liver Cirrhosis/complications
  • Liver Cirrhosis/genetics
  • Liver Cirrhosis/metabolism
  • Liver Cirrhosis/pathology
  • Liver Neoplasms/etiology
  • Liver Neoplasms/genetics*
  • Liver Neoplasms/metabolism
  • Liver Neoplasms/pathology
  • MicroRNAs/genetics*
  • MicroRNAs/metabolism
  • Phosphatidylinositol 3-Kinases/antagonists & inhibitors
  • Phosphatidylinositol 3-Kinases/genetics
  • Phosphatidylinositol 3-Kinases/metabolism
  • Protein Kinase Inhibitors/pharmacology
  • Proto-Oncogene Proteins c-akt/antagonists & inhibitors
  • Proto-Oncogene Proteins c-akt/genetics*
  • Proto-Oncogene Proteins c-akt/metabolism
  • Unfolded Protein Response/genetics
  • Zebrafish
  • Zebrafish Proteins/antagonists & inhibitors
  • Zebrafish Proteins/genetics*
  • Zebrafish Proteins/metabolism
PubMed: 24416389 Full text @ PLoS One
FIGURES
ABSTRACT

Hepatocarcinogenesis commonly involves the gradual progression from hepatitis to fibrosis and cirrhosis, and ultimately to hepatocellular carcinoma (HCC). Endothelin 1 (Edn1) has been identified as a gene that is significantly up-regulated in HBx-induced HCC in mice. In this study, we further investigated the role of edn1 in hepatocarcinogenesis using a transgenic zebrafish model and a cell culture system. Liver-specific edn1 expression caused steatosis, fibrosis, glycogen accumulation, bile duct dilation, hyperplasia, and HCC in zebrafish. Overexpression of EDN1 in 293T cells enhanced cell proliferation and cell migration in in vitro and xenotransplantation assays and was accompanied with up-regulation of several cell cycle/proliferation- and migration-specific genes. Furthermore, expression of the unfolded protein response (UPR) pathway-related mediators, such as spliced XBP1, ATF6, IRE1, and PERK, was also up-regulated at both the RNA and protein levels. In the presence of an EDN1 inhibitor or an AKT inhibitor, these increases were diminished and the EDN1-induced migration ability also was disappeared, suggesting that the EDN1 effects act through activation of the AKT pathway to enhance the UPR and subsequently activate the expression of downstream genes. Additionally, p-AKT is enhanced in the edn1 transgenic fish compared to the GFP-mCherry control. The micro RNA miR-1 was found to inhibit the expression of EDN1. We also observed an inverse correlation between EDN1 and miR-1 expression in HCC patients. In conclusion, our data suggest that EDN1 plays an important role in HCC progression by activating the PI3K/AKT pathway and is regulated by miR-1.

ADDITIONAL INFORMATION